The brain has a waste-disposal system that clears away junk proteins that contribute to the development of dementia and ...

This drug has the potential to be more targeted than others currently being studied, and we hope it will result in fewer ...

Frontotemporal dementia can be hard to diagnose because while dementia can be part of the illness, it's not a factor in all ...

Sage Therapeutics does not plan further clinical development of its dalzanemdor drug candidate in Alzheimer's disease following its failure in a mid-stage study.

Outcomes may improve with disease-modifying drugs and lifestyle change if Alzheimer's could be identified earlier.

(RTTNews) - Sage Therapeutics, Inc. (SAGE) Tuesday said its Phase 2 LIGHTWAVE study to evaluate dalzanemdor in participants with mild cognitive impairment (MCI) or mild dementia due to Alzheimer's ...

Researchers suggest that the way Alzheimer's reshapes our brains is as unique as our fingerprints, challenging long-held ...

Researchers show that a pill form of the drug dronabinol, an FDA-approved synthetic version of marijuana's main ingredient, THC, reduces agitation in patients with Alzheimer's by an average of 30%.

Researchers in China reported finding β-amyloid (Aβ) deposits along the ocular glymphatic system in patients with Alzheimer's ...

Longview residents were out in front of the Gregg County Courthouse on Saturday to take part in the Walk to End Alzheimer’s ...

Researchers at Indiana University School of Medicine are examining the brains of individuals with asymptomatic Alzheimer's ...

Alzheimer’s Disease (AD) is an illness that takes a village to tackle. In its most advanced stages it can be hard on a patient and their care team. According to the National Institute on Aging, ...